XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 7,708 $ 9,521
Accounts receivable 16
Prepaid expenses and other current assets 317 399
Total current assets 8,041 9,920
Long-term restricted cash 10 10
Other long-term assets 13
Total assets 8,051 9,943
Current liabilities:    
Accounts payable 657 809
Accrued expenses and other current liabilities 246 120
Total current liabilities 903 929
Warrant liability 1 67
Total liabilities 904 996
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred Stock, $0.0001 par value — 500,000 shares authorized; 6,746 shares designated Series A convertible preferred stock; no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.0001 par value — 200,000,000 shares authorized; 3,652,285 shares issued and outstanding at March 31, 2025 and December 31, 2024
Additional paid-in capital 306,111 306,103
Accumulated deficit (298,964) (297,156)
Total stockholders’ equity 7,147 8,947
Total liabilities and stockholders’ equity $ 8,051 $ 9,943